ATLANTA (AP) — U.S. health advisers have endorsed the Pfizer COVID-19 vaccine for kids 12 and up.
On Wednesday afternoon, a federal vaccine advisory committee issued recommendations for using the two-dose vaccine in 12- to 15-year-olds.
The FDA announced on Monday the Pfizer-BioNTech coronavirus vaccine has been authorized for emergency use in adolescents 12 to 15 years old.
Previously, only those 16+ were eligible for the vaccine. The company had announced recently they would seek authorization to expand the age range.
Shots could begin as soon as Thursday.
“This is a watershed moment in our ability to fight back the COVID-19 pandemic,” Dr. Bill Gruber, a Pfizer senior vice president who’s also a pediatrician, told The Associated Press.
Studies conducted by Pfizer showed the vaccine not only was safe for teenagers but also nearly eliminated all risks of catching COVID-19.
The company did note that some children have similar reactions to adults from the second shot including fever, chills, and aches.